Volume 140, Issue 2, Pages 425-434.e1 (February 2011) Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease Andreas Tromm, Ivan Bunganič, Eva Tomsová, Zsolt Tulassay, Milan Lukáš, Jan Kykal, Marian Bátovský, Bohumil Fixa, Libor Gabalec, Rifaat Safadi, Heinz–Jochen Kramm, István Altorjay, Hanns Löhr, Ioannis Koutroubakis, Simon Bar–Meir, Davor Štimac, Elke Schäffeler, Christoph Glasmacher, Karin Dilger, Ralf Mohrbacher, Roland Greinwald Gastroenterology Volume 140, Issue 2, Pages 425-434.e1 (February 2011) DOI: 10.1053/j.gastro.2010.11.004 Copyright © 2011 AGA Institute Terms and Conditions
Figure 1 Patient disposition. Gastroenterology 2011 140, 425-434.e1DOI: (10.1053/j.gastro.2010.11.004) Copyright © 2011 AGA Institute Terms and Conditions
Figure 2 Clinical remission at final study visit, defined as CDAI of 150 or less. RCI, repeated CI. Gastroenterology 2011 140, 425-434.e1DOI: (10.1053/j.gastro.2010.11.004) Copyright © 2011 AGA Institute Terms and Conditions